Download PDF
CC BY-NC-ND 4.0 · Arq Neuropsiquiatr 2017; 75(08): 533-538
DOI: 10.1590/0004-282X20170084
ARTICLES

Ankle-brachial index and diabetic neuropathy: study of 225 patients

Index tornozelo-braquial e neuropatia diabética: estudo de 225 pacientes
Liliana Chevtchouk
1   Universidade Federal Fluminense, Departamento de Neurociências, Niterói RJ, Brasil;
,
Marcio Heitor Stelmo da Silva
2   Faculdade de Medicina de Barbacena, Departamento de Estatística, Barbacena MG, Brasil.
,
Osvaldo José Moreira do Nascimento
1   Universidade Federal Fluminense, Departamento de Neurociências, Niterói RJ, Brasil;
› Author Affiliations
› Further Information
Also available at
   Permissions and Reprints

ABSTRACT

Objective To evaluate neuropathic pain and peripheral vascular disease in diabetics and compare this with the length of time since diagnosis in type 1, and type 2 diabetes.

Methods A cross-sectional study with 225 diabetics chosen from their responses on the DN4 questionnaire, who were then evaluated with the ankle-brachial index (ABI), separating type 1 diabetes from type 2 diabetes.

Results A higher incidence of neuropathic pain in those over 60 years of age showed an ABI > 1.3. Neuropathic pain was related to an abnormal ABI in 144 patients (64.2%). A statistically significant value was obtained in type 2 diabetes patients with more than 10 years from disease onset, 69 with altered ABI and 25 with normal ABI. There was an altered ABI (< 0.9) observed in 33% of type 1 diabetes patients and in 67% of type 2 diabetes patients.

Conclusion The ABI test in type 1 diabetes and type 2 diabetes patients is important even in those who are asymptomatic. A diagnosis of more than 10 years prior, regardless of the presence of neuropathic pain or ischemic signs, altered the ABI.

RESUMO

Objetivo Avaliar dor neuropática e doença vascular periférica em diabéticos e comparar com, tempo de diagnóstico de diabetes tipo 1(DM 1) e diabetes tipo 2(DM2).

Métodos Estudo de corte transversal onde, 225 diabéticos responderam ao questionário (DN4) sendo submetidos ao índice tornozelo-braquial (ITB).

Resultados predomínio de dor neuropática foi em pacientes acima de 60 anos com (DM2), com um ITB > 1,3 nesta população; assim a dor neuropática foi relacionada com o ITB anormal em 144 pacientes, total de 64,2%. Um valor estatisticamente significativo foi com (DM2).Um ITB alterado (< 0,9) em 33% no (DM 1) e em 67% (DM 2). Totalizando 132 indivíduos com alterações no ITB.

Conclusão O teste ITB é útil em pacientes com DM 1 e DM 2 quando a dor neuropática é suspeita, mesmo em assintomáticos. E o tempo prolongado de diabetes (> 10 anos), independentemente da presença de dor ou sinais isquêmicos, alterou o ITB.

diabetes mellitus - diabetic neuropathies - ankle-brachial index
diabetes mellitus - neropatias diabéticas - índice tornozelo-braquial


Publication History

Received: 18 November 2016

Accepted: 15 April 2017

Article published online:
05 September 2023

© 2023. Academia Brasileira de Neurologia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

 

  • References

  • 1 Standards of Medical Care in Diabetes-2016: summary of revisions. Diabetes Care. 2016;39 Suppl 1:S4-5. https://doi.org/10.2337/dc16-S003
  • 2 American Diabetes Association. Executive summary: standards of medical care in diabetes-2012. Diabetes Care. 2012;35(Supp 1):S4-10. https://doi.org/10.2337/dc12-s004
  • 3 American Diabetes Association. Economic costs of diabetes in the USA in 2007. Diabetes Care. 2008;31(3):596-615. https://doi.org/10.2337/dc08-9017
  • 4 Tesfaye S, Boulton AJ, Dyck PJ, Freeman R, Horowitz M, Kempler P et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care. 2010;33(10):2285-93. https://doi.org/10.2337/dc10-1303
  • 5 Mills JL, Armstrong DG, Lavery L. Evaluation and management of peripheral arterial disease. In: Armstrong DG, Lavery L. Clinical care in diabetic foot. 2nd ed. New York: American Diabetes Association; 2005. p. 99-106.
  • 6 Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2007;27(5):1047-53. https://doi.org/10.2337/diacare.27.5.1047
  • 7 Vlassara H, Striker GE. Advanced glycation endproducts in diabetes and diabetic complications. Endocrin Metab Clin N Am. 2013;42(4):697-719. https://doi.org/10.1016/j.ecl.2013.07.005
  • 8 Pasnoor M, Dimachkie MM, Kluding P, Barohn RJ. Diabetic neuropathy part 1: overview and symmetric phenotypes. Neurol Clin. 2013;31(2):425-45. https://doi.org/10.1016/j.ncl.2013.02.004
  • 9 Schestatsky P, Nascimento OJ. What do general neurologists need to know about neuropathic pain?. Arq Neuropsiquiatr. 2009;67(3A):741-9. https://doi.org/10.1590/S0004-282X2009000400039
  • 10 Vinik AI, Nevoret ML, Casellini C, Parson H. Diabetic neuropathy. Endocrinol Metab Clin N Am. 2013;42(4):747-87. https://doi.org/10.1016/j.ecl.2013.06.001
  • 11 Spallone V, Morganti R, D’Amato C, Cacciotti L, Fedele T, Maiello MR et al. Clinical correlates of painful diabetic neuropathy and relationship of neuropathic pain with sensorimotor and autonomic nerve function. Eur J Pain. 2011;15(2):153-60. https://doi.org/10.1016/j.ejpain.2010.06.011
  • 12 Drummond JP, Marques JO, Nascimento OJM. Dor neuropática: fisiopatologia, clínica e terapêutica. São Paulo: Âmbito; 2007.
  • 13 Potier L, Abi Khalil C, Mohammedi K, Roussel R. Use and utility of ankle brachial index in patients with diabetes. Eur J Vasc Endovasc Surg. 2011;41(1):110-6. https://doi.org/10.1016/j.ejvs.2010.09.020
  • 14 Triches C, Schaan BD, Gross JL, Azevedo MJ. [Macrovascular diabetic complications: clinical characteristics, diagnosis and management]. Arq Bras Endocrinol Metabol. 2009;53(6):698-708. Portuguese. https://doi.org/10.1590/S0004-27302009000600002
  • 15 Aboyans V, Ho E, Denenberg JO, Ho LA, Natarajan L, Criqui MH. The association between elevated ankle systolic pressures and peripheral occlusive arterial disease in diabetic and nondiabetic subjects. J Vasc Surg. 2008;48(5):1197-203. https://doi.org/10.1016/j.jvs.2008.06.005
  • 16 Vamos EP, Bottle A, Edmonds ME, Valabhjl JMajeed A, Millett C. Changes in the incidence of lower extremity amputations in individuals with and without diabetes in England between 2004 and 2008. Diabetes Care. 2010;33(12):2593-7. https://doi.org/10.2337/dc10-0989
  • 17 Holman N, Young RJ, Jeffcoate WJ. Variations of recorded incidence of amputation of the lower limbs. Diabetologia. 2012;55(7):1919-25. https://doi.org/10.1007/s00125-012-2468-6
  • 18 Brownrigg JR, Apelqvist J, Bakker K, Schaper NC, Hinchliffe RJ. Evidence based management of PAD and the diabetic foot. Eur J Vas Endovasc Surg. 2013;45(6):673-81. https://doi.org/10.1016/j.ejvs.2013.02.014
  • 19 Bakker K, Schaper NC. The development of global consensus guidelines on the management and prevention of the Diabetic Foot 2011. Diabetes Metab Res Rev. 2012;28 Suppl 1:116-8. https://doi.org/10.1002/dmrr.2254
  • 20 Backonja MM, Krause SJ Neuropathic pain questionnaire: short form. Clin J Pain. 2003;19(5):315-6. https://doi.org/10.1097/00002508-200309000-00005
  • 21 Bouhassira D, Attal N, Alchaar H, Boureau F, Brochet B, Bruxelle J et al.Comparison of pain syndrome associated with nervous or somatic lesions and development of new neuropathic pain diagnostic questionnaire (DN4). Pain. 2005;114(1-2):29-36. https://doi.org/10.1016/j.pain.2004.12.010
  • 22 Resende MA, Nascimento OJ, Rios AA, Quintanilha G, Ceballos LE, Araújo FP et al. Neuropathic pain profile: the basic neurological exam of 33 patients. Rev Bras Anestesiol. 2010;60(2):144-53. https://doi.org/10.1590/S0034-70942010000200006
  • 23 Abbott CA, Malik RA, Ross ER, Kulkarni J, Boulton AJ. Prevalence and character of painful diabetic neuropathy in a large community-based in population in the UK. Diabetes Care. 2011;34(10):2220-4. https://doi.org/10.2337/dc11-1108
  • 24 Dyck PJ, Albers JW, Andersen H, Arezzo JC, Biessels GJ, Bril V et al. Diabetic polyneuropathies: update on research definition, diagnostic criteria and estimation of severity. Diabetes Metab Res Rev. 2011;27(7):620-8. https://doi.org/10.1002/dmrr.1226
  • 25 Jeffcoate WJ, Rasmussen LM, Hofbauer LC, Game FL. Medial arterial calcification in diabetes and relationship to neuropathy. Diabetologia. 2009;52(12):2478-88. https://doi.org/10.1007/s00125-009-1521-6
  • 26 Stettler C, Allemann S, Jüni P, Cull CA, Holman RR, Egger M et al. Glycemic Control and Macrovascular disease in type 1 and type 2 diabetes mellitus: meta-analysis of randomized trials. Am Heart J. 2006;152(1):27-38. https://doi.org/10.1016/j.ahj.2005.09.015
  • 27 Holland-Letz T, Endres HG, Biedermann S, Mahn M, Kunert J, Groh S et al. Reproducibility and reability of the ankle braquial index as assessed by vascular experts, family physicians and nurses. Vasc Med. 2007;12(2):105-12. https://doi.org/10.1177/1358863X07077281
  • 28 Hecke O, Austin SK, Khan RA, Smith BH, Torrance N. Neuropatic pain in the general population: a systematic review of epidemiological studies. Pain. 2014;155(4):654-62. https://doi.org/10.1016/j.pain.2013.11.013